Table 2. Summary information providing an overview of the data included in the data analysis using the DHS data and published literature included in the meta-analysis.
| DHS Analysis Data | Meta-Analysis Data | |
|---|---|---|
| N studies | 57 | 43 |
| Year data collection (range) | Nov 2006–Dec 2018 | Apr 2006–May 2019 |
| Continental region, N (n unique countries)a | ||
| African | 57 (23) | 17 (7) |
| Americas | 0 | 8 (4) |
| Asia | 0 | 15 (7) |
| Pacific and Middle East | 0 | 3 (2) |
| All age surveys versus children only, % (n/N studies) | 10.5% (6/57) | 97.7% (42/43) |
| Median age surveyed (min–max) | 2 (2–7) | 22 (0.5–100)a |
| Sex, % male (cluster range) | 50.5 (47.0–52.3) | 54.0 (31.9–100)b |
| N individuals sampled (n malaria positive) | 420,659 (59,050) | 132,590 (11,349) |
| Median age of malaria positive (min–max) | 3 (2–5) | 22 (0.5–90)a |
| % Male malaria positive (cluster range) | 50.9 (46.0–53.2) | 47.0 (37.8–56.2)b |
| Number of individuals per model type (n malaria positive) | ||
| RACD versus community | 72,498 (24,836) | 5,661 (288) |
| RACD versus neighbours | 0 | 23,497 (564) |
| MSAT | 177,243 (50,590) | 40,851 (6,238) |
| MTAT | 208,140 (59,050) | 62,581 (4,259) |
a22 records did not report age in a relevant format.
b10 records did not report gender in a relevant format to extract.
Abbreviations: DHS, demographic health survey; MSAT, Mass Screen and Treat; MTAT, Mass Test and Treat; RACD, Reactive Case Detection